The 1 st International NASH Day is designed to spread scientific and medical knowledge in the general population, with events that will feature informative and educational on-site activities in several cities/countries at the same time, as well as a massive online activity.
NASH is an acronym that stands for Non-Alcoholic SteatoHepatitis. It is the most severe form of non-alcoholic fatty liver disease (NAFLD), and is characterized by the presence of an abnormal accumulation of fat in the liver which in some individuals can progress to liver cell injury (hepatocellular ballooning) and inflammation.
The stages of NAFLD: From simple fatty liver to irreversible cirrhosis
NAFLD can progress from steatosis, to non-alcoholic steatohepatitis (NASH) and then to cirrhosis, hepatocellular carcinoma (HCC) and end-stage liver disease (ESLD). In its early stages, NAFLD can be treated through diet and lifestyle changes, such as losing weight.4 NAFLD-related HCC accounted for 4-22%% of all HCC recorded cases.
In Europe, NAFLD and NASH coded as cause of death are most common in Ireland, Hungary, Luxembourg and the United Kingdom. In Europe, prevalence of NASH is estimated to be up to 5%.
To learn more about the 1st International NASH Day, visit: The NASH Education Program
To review the EASL Clinical Practice Guidelines (CPG) slide decks, visit: https://ilc-congress.eu/slide-decks/#CPGs-slide-decks
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off